Shares of Beta Bionics fell after the maker of insulin-delivery systems shared preliminary data for new patient starts that were below expectations. The stock slipped 36%, to $20.5, on Friday. Over ...
The downgrade comes after the Irvine-based medical device company reported preliminary fourth quarter results.
IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary, ...
Beta Bionics (BBNX) reported preliminary, unaudited Q4 2025 net sales of at least $32M, compared to estimate of $28.9M, ...
In 2024, medtech IPOs began to come back, thanks to the likes of heart valve company Anteris Technologies and neurotech ...
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Beta Bionics, Inc. ("Beta Bionics" or "the Company") (NASDAQ: ...
Barchart on MSN
Applied Digital just sent little-known Ekso Bionics stock soaring. Should you buy shares here?
Ekso Bionics (EKSO) shares nearly doubled on Dec. 30 after Applied Digital (APLD) revealed plans of spinning off its cloud ...
The catalyst for Ekso's impressive stock performance was the news that Applied Digital is pursuing a separation of its cloud segment into a standalone entity. This announcement was made on a day when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback